Huang Qingfang, Yang Chao, Pang Jinmeng, Zeng Biao, Yang Pei, Zhou Rongrong, Wu Haijun, Shen Liangfang, Zhang Rong, Lou Fan, Jin Yi, Abdilim Albert, Jin Hekun, Zhang Zijian, Xie Xiaoxue
Department of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital, Changsha, Hunan, China.
Front Oncol. 2023 Oct 25;13:1168995. doi: 10.3389/fonc.2023.1168995. eCollection 2023.
This study aims to develop and validate a model predictive for the incidence of grade 4 radiation-induced lymphopenia (G4RIL), based on dosiomics features and radiomics features from the planning CT of nasopharyngeal carcinoma (NPC) treated by radiation therapy.
The dataset of 125 NPC patients treated with radiotherapy from August 2018 to March 2019 was randomly divided into two sets-an 85-sample training set and a 40-sample test set. Dosiomics features and radiomics features of the CT image within the skull bone and cervical vertebrae were extracted. A feature selection process of multiple steps was employed to identify the features that most accurately forecast the data and eliminate superfluous or insignificant ones. A support vector machine learning classifier with correction for imbalanced data was trained on the patient dataset for prediction of RIL (positive classifier for G4RIL, negative otherwise). The model's predictive capability was gauged by gauging its sensitivity (the likelihood of a positive test being administered to patients with G4RIL) and specificity in the test set. The area beneath the ROC curve (AUC) was utilized to explore the association of characteristics with the occurrence of G4RIL.
Three clinical features, three dosiomics features, and three radiomics features exhibited significant correlations with G4RIL. Those features were then used for model construction. The combination model, based on nine robust features, yielded the most impressive results with an ACC value of 0.88 in the test set, while the dosiomics model, with three dosiomics features, had an ACC value of 0.82, the radiomics model, with three radiomics features, had an ACC value of 0.82, and the clinical model, with its initial features, had an ACC value of 0.6 for prediction performance.
The findings show that radiomics and dosiomics features are correlated with the G4RIL of NPC patients. The model incorporating radiomics features and dosiomics features from planning CT can predict the incidence of G4RIL in NPC patients.
本研究旨在基于放射剂量组学特征和鼻咽癌(NPC)放射治疗计划CT的影像组学特征,开发并验证一个预测4级放射性淋巴细胞减少症(G4RIL)发生率的模型。
将2018年8月至2019年3月接受放射治疗的125例NPC患者的数据集随机分为两组——一个85样本的训练集和一个40样本的测试集。提取颅骨和颈椎内CT图像的放射剂量组学特征和影像组学特征。采用多步骤特征选择过程来识别最准确预测数据的特征,并消除多余或无意义的特征。在患者数据集上训练一个对不平衡数据进行校正的支持向量机学习分类器,以预测放射性淋巴细胞减少症(RIL,G4RIL为阳性分类,否则为阴性)。通过测量模型在测试集中的敏感性(对G4RIL患者进行阳性检测的可能性)和特异性来评估模型的预测能力。利用ROC曲线下面积(AUC)来探索特征与G4RIL发生之间的关联。
三个临床特征、三个放射剂量组学特征和三个影像组学特征与G4RIL显著相关。然后将这些特征用于模型构建。基于九个稳健特征的组合模型在测试集中取得了最令人印象深刻的结果,ACC值为0.88,而具有三个放射剂量组学特征的放射剂量组学模型ACC值为0.82,具有三个影像组学特征的影像组学模型ACC值为0.82,具有初始特征的临床模型预测性能ACC值为0.6。
研究结果表明,影像组学和放射剂量组学特征与NPC患者的G4RIL相关。结合放射治疗计划CT的影像组学特征和放射剂量组学特征的模型可以预测NPC患者G4RIL的发生率。